Comparing The Efficacy Of Local Triamcinolone Injection In Carpal Tunnel Syndrome Using Three Different Approaches with or without Ultrasound Guidance

Source: Journal of Pain Research - Category: Anesthesiology Tags: Journal of Pain Research Source Type: research

Related Links:

This study focused on the efficacy of each modality, in combination with a wrist orthosis, in treating patients with carpal tunnel syndrome to relieve symptoms and improve function. Modalities and splints are preparatory methods that can decrease pain and promote healing, in preparation for occupational performance (American Occupational Therapy Association [AOTA], 2014). Physical agent modalities, if used, must be incorporated with occupational therapy interventions as a preparatory method for the purpose of regaining function for occupations (AOTA, 2014).
Source: Journal of Hand Therapy - Category: Rehabilitation Authors: Source Type: research
Abstract Background: Carpal tunnel syndrome (CTS) is the most frequent entrapment neuropathy in humans. Nonsurgical management is still a matter of debate, and conservative treatments include splinting, local steroid injections, ultrasound, and oral steroids. Acupuncture and electroacupuncture therapy for symptomatic CTS may improve symptoms and aid nerve repair as well as improve sensory and motor functions. However, limited evidence based on comprehensive evaluation methods is available regarding the effects of those treatments. Objective: The study intended to compare the short-term effects of acupuncture ...
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Tags: Altern Ther Health Med Source Type: research
Abstract BACKGROUND: Carpal tunnel syndrome is diagnosed based on history, physical examination, and nerve conduction testing; however, there are no clear criteria for the diagnosis of carpal tunnel syndrome. Recently, studies have aimed to diagnose carpal tunnel syndrome through ultrasound or MRI. The purpose of this study was to compare and analyze the cross-sectional area of the median nerve between patients with carpal tunnel syndrome and a control group. METHODS: From July 2015 to August 2017, we retrospectively analyzed fishery and white-collar workers (164 people, 37 men, 127 women). Carpal tunnel synd...
Source: Asian Journal of Surgery - Category: Surgery Authors: Tags: Asian J Surg Source Type: research
ConclusionPlatelet-rich plasma could be effective treatment of mild to moderate idiopathic CTS and superior to corticosteroid in improving pain, function, and distal sensory latency of median nerve.Trial Identifier: NCT03863873Key Points:•PRP is effective treatment of mild to moderate CTS.•PRP is superior to corticosteroids in improving pain and function in CTS.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
Conclusions: The results of this study may suggest the clinical efficacy of LLLT or ultrasound combined with gliding exercises in patients with mild to moderate CTS.
Source: Indian Journal of Orthopaedics - Category: Orthopaedics Authors: Source Type: research
DISCUSSION: Neuromuscular ultrasound and NCS/EMG combined techniques helped in the differential diagnosis between CTS and C6-7 nerve roots radiculopathy. In this case, physical examination could not give an immediate conclusive answer. PMID: 30601727 [PubMed - as supplied by publisher]
Source: The Neurodiagnostic Journal - Category: Neurology Tags: Neurodiagn J Source Type: research
Publication date: October 2018Source: PM&R, Volume 10, Issue 10Author(s): Erek W. Latzka, P. Troy Henning, Adam M. PourchoAbstractCarpal tunnel syndrome is the most common entrapment neuropathy, resulting in 500,000 carpal tunnel release (CTR) surgeries and a total cost of more than 2 billion dollars annually in the United States. Although initially performed via a large (3-5 cm) palmar incision, CTR techniques have continually evolved to reduce incision size, recovery times, postoperative pain, and improve cosmesis and clinical outcomes. More recently, multiple authors have reported excellent results after ultrasound-guid...
Source: PMandR - Category: Rehabilitation Source Type: research
ObjectivePerineural injection with 5% dextrose (D5W) is a novel strategy in the treatment of carpal tunnel syndrome (CTS). In contrast, perineural injection with corticosteroid has been used for decades for treating CTS, but possible neurotoxicity has been a major concern. No studies investigating the comparative effects have been published so far. The authors performed a prospective, randomized, double ‐blinded, head‐to‐head comparative trial to compare these two approaches for patients having mild‐to‐moderate CTS.MethodsFifty ‐four participants with mild‐to‐moderate CTS were randomly divided into dextrose...
Source: Annals of Neurology - Category: Neurology Authors: Tags: Research Article Source Type: research
Authors: Çatalbaş N, Akkaya N, Atalay NS, Sahin F Abstract BACKGROUND: Clinical and electrophysiological effects of therapeutic ultrasound (US) were researched in many studies on patients with CTS with conflicting results. OBJECTIVE: To assess the effects of continuous and pulsed US treatments by ultrasonographic imaging in addition to clinical and electrophysilogical parameters in patients with carpal tunnel syndrome (CTS). METHOD: Fifty-four patients with idiopathic CTS were randomly divided into three groups. All patients used night splints for two weeks. In addition to splint therapy, continuous...
Source: Journal of Back and Musculoskeletal Rehabilitation - Category: Orthopaedics Tags: J Back Musculoskelet Rehabil Source Type: research
The FDA group reviewing the 510(k) application for Pavmed‘s (NSDQ:PAVM) CarpX device wants the company to resubmit the application. The FDA told the company that it had not reached a consensus within the review period set by the agency’s rules. To extend the review process, the FDA recommended that Pavmed resubmit the application. In a filing with the SEC, Pavmed said it initiated the submission this week and hopes to land a pre-submission meeting in the next 45 days. The company’s minimally-invasive CarpX device is designed to treat carpal tunnel syndrome. The device enables a physician to relieve c...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Food & Drug Administration (FDA) Pain Management Regulatory/Compliance Pavmed Source Type: news
More News: Anesthesiology | Carpal Tunnel Syndrome | Pain | Triamcinolone | Ultrasound